HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cyclin-Dependent Kinase Inhibitor p57

A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.
Also Known As:
CDKN1C Protein; Cyclin Kinase Inhibitor Protein 2; Cyclin-Dependent Kinase Inhibitor 1C; p57 KIP2 Protein; p57KIP2 Protein; Cyclin Dependent Kinase Inhibitor 1C; Cyclin Dependent Kinase Inhibitor p57; KIP2 Protein, p57
Networked: 38 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Yue, Hui: 4 articles (08/2005 - 02/2003)
2. Matsuura, N: 3 articles (10/2001 - 01/2001)
3. Huang, Tim H-M: 2 articles (01/2014 - 06/2011)
4. Joseph, B: 2 articles (01/2012 - 11/2009)
5. Vlachos, P: 2 articles (01/2012 - 11/2009)
6. Fukunaga, Masaharu: 2 articles (08/2004 - 12/2002)
7. Feng, Xin-Li: 2 articles (07/2003 - 02/2003)
8. Ma, Shu-Ren: 2 articles (07/2003 - 02/2003)
9. Song, Fu-Lin: 2 articles (07/2003 - 02/2003)
10. Tsujimoto, M: 2 articles (10/2001 - 01/2001)

Related Diseases

1. Triploidy
2. Type 2 Diabetes Mellitus (MODY)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)
4. Neoplasms (Cancer)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Cyclin-Dependent Kinase 4
2. Formaldehyde (Formol)
3. Messenger RNA (mRNA)
4. Cyclin E
5. Proliferating Cell Nuclear Antigen (PCNA)
6. Proteins (Proteins, Gene)
7. Cyclin-Dependent Kinase 2
8. Small Interfering RNA (siRNA)
9. Telomerase (Telomerase Reverse Transcriptase)
10. Carboplatin (JM8)